These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 26688950)
1. [Levels of programmed death-1 and programmed death ligand-1 in the peripheral blood of patients with oral squamous cell carcinoma and its clinical implications]. Zhang P; Ouyang S; Wang J; Huang Z; Wang J; Liao L Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Oct; 33(5):529-33. PubMed ID: 26688950 [TBL] [Abstract][Full Text] [Related]
2. Differential expression of programmed death-1 and its ligand, programmed death ligand-1 in oral squamous cell carcinoma with and without oral submucous fibrosis. Quan H; Liu S; Shan Z; Liu Z; Chen T; Hu Y; Yao Z; Fang L Arch Oral Biol; 2020 Nov; 119():104916. PubMed ID: 32977151 [TBL] [Abstract][Full Text] [Related]
3. Enhanced programmed death 1 (PD-1) and PD-1 ligand (PD-L1) expression in patients with actinic cheilitis and oral squamous cell carcinoma. Malaspina TS; Gasparoto TH; Costa MR; de Melo EF; Ikoma MR; Damante JH; Cavassani KA; Garlet GP; da Silva JS; Campanelli AP Cancer Immunol Immunother; 2011 Jul; 60(7):965-74. PubMed ID: 21442435 [TBL] [Abstract][Full Text] [Related]
4. [Expression of soluble programmed death-1, soluble programmed death ligand 1 proteins and immune status in patients with oral lichen planus]. Luo L; Shu M; Li S; Cai Y Zhonghua Kou Qiang Yi Xue Za Zhi; 2015 Oct; 50(10):585-9. PubMed ID: 26757624 [TBL] [Abstract][Full Text] [Related]
5. Expression of immunoregulatory molecules PD-L1 and PD-1 in oral cancer and precancerous lesions: A cohort study of Japanese patients. Kouketsu A; Sato I; Oikawa M; Shimizu Y; Saito H; Takahashi T; Kumamoto H J Craniomaxillofac Surg; 2019 Jan; 47(1):33-40. PubMed ID: 30466788 [TBL] [Abstract][Full Text] [Related]
6. Expression of programmed cell death-ligand 1 in oral squamous cell carcinoma and oral leukoplakia is associated with disease progress and CD8+ tumor-infiltrating lymphocytes. Chen XJ; Tan YQ; Zhang N; He MJ; Zhou G Pathol Res Pract; 2019 Jun; 215(6):152418. PubMed ID: 31027907 [TBL] [Abstract][Full Text] [Related]
7. [Programmed cell death protein 1 and its ligands regulate immune balance in allergic rhinitis]. Wen SL; Li F; Zhao F; Zuo JJ; Deng YQ; Zhang W; Tao ZZ Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Apr; 55(4):384-390. PubMed ID: 32306637 [No Abstract] [Full Text] [Related]
8. Significant association of increased PD-L1 and PD-1 expression with nodal metastasis and a poor prognosis in oral squamous cell carcinoma. Maruse Y; Kawano S; Jinno T; Matsubara R; Goto Y; Kaneko N; Sakamoto T; Hashiguchi Y; Moriyama M; Toyoshima T; Kitamura R; Tanaka H; Oobu K; Kiyoshima T; Nakamura S Int J Oral Maxillofac Surg; 2018 Jul; 47(7):836-845. PubMed ID: 29395669 [TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of PD-L2 expression in patients with oral squamous cell carcinoma-A comparison to the PD-L1 expression profile. Weber M; Wehrhan F; Baran C; Agaimy A; Büttner-Herold M; Kesting M; Ries J Cancer Med; 2019 Mar; 8(3):1124-1134. PubMed ID: 30659749 [TBL] [Abstract][Full Text] [Related]
10. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1 Ma SR; Liu JF; Jia R; Deng WW; Jia J Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594 [TBL] [Abstract][Full Text] [Related]
11. [Soluble programmed death-1 and soluble programmed death ligand 1 protein expression and immune status in patients with recurrent aphthous ulcer]. Nan J; Liang L; Li L; Xiaoqin S; Xing J; Yang C Hua Xi Kou Qiang Yi Xue Za Zhi; 2017 Jun; 35(3):286-290. PubMed ID: 28675014 [TBL] [Abstract][Full Text] [Related]
12. Relationship between the expressions of PD-L1 and tumor-infiltrating lymphocytes in oral squamous cell carcinoma. Cho YA; Yoon HJ; Lee JI; Hong SP; Hong SD Oral Oncol; 2011 Dec; 47(12):1148-53. PubMed ID: 21911310 [TBL] [Abstract][Full Text] [Related]
13. Relationship of programmed death ligand-1 expression with clinicopathological features and prognosis in patients with oral squamous cell carcinoma: A meta-analysis. He J; Chen XF; Xu MG; Zhao J Arch Oral Biol; 2020 Jun; 114():104717. PubMed ID: 32344357 [TBL] [Abstract][Full Text] [Related]
14. Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin's lymphoma. Feng X; Luo X; Yang Y; Fan Y; Ye Q Medicine (Baltimore); 2023 Nov; 102(44):e35757. PubMed ID: 37933048 [TBL] [Abstract][Full Text] [Related]
15. CD163 Kubota K; Moriyama M; Furukawa S; Rafiul HASM; Maruse Y; Jinno T; Tanaka A; Ohta M; Ishiguro N; Yamauchi M; Sakamoto M; Maehara T; Hayashida JN; Kawano S; Kiyoshima T; Nakamura S Sci Rep; 2017 May; 7(1):1755. PubMed ID: 28496107 [TBL] [Abstract][Full Text] [Related]
16. [The level of soluble programmed death-1 in peripheral blood of patients with lung cancer and its clinical implications]. Xing YF; Zhang ZL; Shi MH; Ma Y; Chen YJ Zhonghua Jie He He Hu Xi Za Zhi; 2012 Feb; 35(2):102-6. PubMed ID: 22455965 [TBL] [Abstract][Full Text] [Related]
17. The interaction between the soluble programmed death ligand-1 (sPD-L1) and PD-1 Li X; Du H; Zhan S; Liu W; Wang Z; Lan J; PuYang L; Wan Y; Qu Q; Wang S; Yang Y; Wang Q; Xie F Front Immunol; 2022; 13():830606. PubMed ID: 35935985 [TBL] [Abstract][Full Text] [Related]
18. Deubiquitination and stabilization of programmed cell death ligand 1 by ubiquitin-specific peptidase 9, X-linked in oral squamous cell carcinoma. Jingjing W; Wenzheng G; Donghua W; Guangyu H; Aiping Z; Wenjuan W Cancer Med; 2018 Aug; 7(8):4004-4011. PubMed ID: 29992764 [TBL] [Abstract][Full Text] [Related]
19. Programmed cell death-ligand 1 expression in oral squamous cell carcinoma is associated with an inflammatory phenotype. Satgunaseelan L; Gupta R; Madore J; Chia N; Lum T; Palme CE; Boyer M; Scolyer RA; Clark JR Pathology; 2016 Oct; 48(6):574-80. PubMed ID: 27590194 [TBL] [Abstract][Full Text] [Related]
20. The significance of PD-1/PD-L1 imbalance in ulcerative colitis. Shi W; Zhang Y; Hao C; Guo X; Yang Q; Du J; Hou Y; Cao G; Li J; Wang H; Fang W PeerJ; 2023; 11():e15481. PubMed ID: 37273534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]